CDK5-IN-2 is a highly selective inhibitor of CDK5, with IC50 values of 0.2 nM against CDK5/p25 and 23 nM against CDK2/CycA; it is used as a research tool to study CDK5-related biological processes and potential therapeutic applications in neurodegenerative diseases and cancer.